DK1523985T3 - Ikke-radioaktivt strontiumholdigt middel til behandling af kræft - Google Patents
Ikke-radioaktivt strontiumholdigt middel til behandling af kræftInfo
- Publication number
- DK1523985T3 DK1523985T3 DK03103850.8T DK03103850T DK1523985T3 DK 1523985 T3 DK1523985 T3 DK 1523985T3 DK 03103850 T DK03103850 T DK 03103850T DK 1523985 T3 DK1523985 T3 DK 1523985T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- containing agent
- radioactive strontium
- prophylaxis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 229910052712 strontium Inorganic materials 0.000 title abstract 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103850A EP1523985B1 (en) | 2003-10-17 | 2003-10-17 | Non-radioactive strontium agent for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1523985T3 true DK1523985T3 (da) | 2010-05-31 |
Family
ID=34354592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03103850.8T DK1523985T3 (da) | 2003-10-17 | 2003-10-17 | Ikke-radioaktivt strontiumholdigt middel til behandling af kræft |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070031476A1 (da) |
| EP (1) | EP1523985B1 (da) |
| CN (1) | CN1886143B (da) |
| AT (1) | ATE460168T1 (da) |
| AU (1) | AU2004281559B2 (da) |
| DE (1) | DE60331654D1 (da) |
| DK (1) | DK1523985T3 (da) |
| ES (1) | ES2342461T3 (da) |
| NO (1) | NO20062229L (da) |
| RU (1) | RU2363479C2 (da) |
| WO (1) | WO2005037295A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI122450B (fi) * | 2007-12-28 | 2012-01-31 | Neurofood Ab Oy | Koostumus steriilin inflammaation hoitoon |
| JP2013534243A (ja) * | 2010-08-18 | 2013-09-02 | コルゲート・パーモリブ・カンパニー | オーラルケア製品およびその使用法および製造法 |
| FI123756B (fi) * | 2010-09-21 | 2013-10-31 | Neurofood Ab Oy | Parannettu lisäravinne syövän hoitamiseksi tai ennaltaehkäisemiseksi |
| EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| US9301945B2 (en) * | 2011-07-21 | 2016-04-05 | Emory University | Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation |
| DK3173382T3 (da) * | 2014-07-21 | 2023-03-13 | Oxolife Sl | Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB602029A (en) * | 1942-04-17 | 1948-05-19 | Western Condensing Co | Improvements in or relating to process of manufacturing a vitamin concentrate |
| GB602209A (en) * | 1945-06-13 | 1948-05-21 | Norton Co | Hydraulic table reciprocating mechanism |
| EP0366869A3 (en) * | 1988-10-17 | 1991-06-12 | Lycon Ag | Bacteriostatic, bactericidal and antifungal composition and methods of use thereof |
| CN1082845A (zh) | 1992-12-21 | 1994-03-02 | 颜怀玮 | 营养平衡强化型矿泉水及制造方法 |
| CN1053091C (zh) * | 1993-03-13 | 2000-06-07 | 彭建汉 | 天然竹汁保健饮料 |
| CN1113720A (zh) * | 1994-05-24 | 1995-12-27 | 云南智成科技实业公司 | 保健液及其生产方法 |
| US5650316A (en) * | 1994-06-06 | 1997-07-22 | Research Development Foundation | Uses of triplex forming oligonucleotides for the treatment of human diseases |
| EP0737471A3 (fr) * | 1995-04-10 | 2000-12-06 | L'oreal | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
| FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| CN1153053A (zh) * | 1995-12-28 | 1997-07-02 | 汪贵昌 | 一种治疗肿瘤的克癌灵中药 |
| US5916143A (en) * | 1996-04-30 | 1999-06-29 | Apple; Marc G. | Brachytherapy catheter system |
| CA2339473A1 (en) * | 1998-08-04 | 2000-02-17 | John V. Kosbab | Nutrient and therapeutic compositions for the treatment of cancer |
| EP1211955A1 (en) | 1999-08-30 | 2002-06-12 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| US20030199615A1 (en) * | 1999-12-09 | 2003-10-23 | Cyril Chaput | Mineral-polymer hybrid composition |
| US6456680B1 (en) * | 2000-03-29 | 2002-09-24 | Tci Incorporated | Method of strontium-89 radioisotope production |
| NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
| JP2005533001A (ja) * | 2002-03-04 | 2005-11-04 | メディミューン，インコーポレーテッド | インテグリンαｖβ３アンタゴニストを他の物質と併用投与する癌の予防または治療方法 |
-
2003
- 2003-10-17 ES ES03103850T patent/ES2342461T3/es not_active Expired - Lifetime
- 2003-10-17 DK DK03103850.8T patent/DK1523985T3/da active
- 2003-10-17 AT AT03103850T patent/ATE460168T1/de not_active IP Right Cessation
- 2003-10-17 EP EP03103850A patent/EP1523985B1/en not_active Expired - Lifetime
- 2003-10-17 DE DE60331654T patent/DE60331654D1/de not_active Expired - Lifetime
-
2004
- 2004-10-15 US US10/575,752 patent/US20070031476A1/en not_active Abandoned
- 2004-10-15 CN CN2004800350230A patent/CN1886143B/zh not_active Expired - Fee Related
- 2004-10-15 RU RU2006115785/15A patent/RU2363479C2/ru not_active IP Right Cessation
- 2004-10-15 WO PCT/FI2004/000618 patent/WO2005037295A1/en active Application Filing
- 2004-10-15 AU AU2004281559A patent/AU2004281559B2/en not_active Ceased
-
2006
- 2006-05-18 NO NO20062229A patent/NO20062229L/no not_active Application Discontinuation
-
2009
- 2009-11-30 US US12/626,980 patent/US8703211B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1523985B1 (en) | 2010-03-10 |
| RU2006115785A (ru) | 2007-11-27 |
| AU2004281559A1 (en) | 2005-04-28 |
| US20070031476A1 (en) | 2007-02-08 |
| NO20062229L (no) | 2006-05-18 |
| AU2004281559B2 (en) | 2010-04-01 |
| ES2342461T3 (es) | 2010-07-07 |
| CN1886143A (zh) | 2006-12-27 |
| DE60331654D1 (de) | 2010-04-22 |
| CN1886143B (zh) | 2011-04-06 |
| US20100074968A1 (en) | 2010-03-25 |
| US8703211B2 (en) | 2014-04-22 |
| RU2363479C2 (ru) | 2009-08-10 |
| EP1523985A1 (en) | 2005-04-20 |
| WO2005037295A1 (en) | 2005-04-28 |
| ATE460168T1 (de) | 2010-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1505990T3 (da) | Fremgangsmåder til behandling af hepatitis | |
| SE0301700D0 (sv) | Novel compounds | |
| RS20060320A (en) | Substituted indazole-o-glucosides | |
| SG130189A1 (en) | Substituted indole-o-glucosides | |
| BR0307058A (pt) | N-óxidos de derivados de n-fenil-2-pirimidina-amina | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| PL376409A1 (en) | Composition for the treatment of infection by flaviviridae viruses | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| TW200716088A (en) | Formulations and methods for treating amyloidosis | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| NO20054535L (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| DE60223576D1 (de) | Hautbehandlungszusammensetzung | |
| SE0301650D0 (sv) | Novel compounds | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
| NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
| SE0300457D0 (sv) | Novel compounds | |
| DK2042182T3 (da) | Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet. | |
| BR0111785A (pt) | Composições e métodos para tratamento de candidìase | |
| ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| DK1521752T3 (da) | Makrocykliske forbindelser til behandling af cancer |